— Know what they know.
Not Investment Advice

OTLC OTC

Oncotelic Therapeutics, Inc.
1W: -17.0% 1M: -40.7% 3M: -49.9% YTD: -73.0% 1Y: -69.5% 3Y: -30.0% 5Y: -83.8%
$0.02
-0.00 (-1.41%)
 
Weekly Expected Move ±11.9%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 40 · $9.3M mcap · 223M float · 0.126% daily turnover · Short 75% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$247M
Net Income
+6403.6% YoY
$-2M
Free Cash Flow
-182.2% YoY
100.0%
Gross Margin
-337.4%
Op. Margin
155.3%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE0.0%
ROA0.0%
ROIC-0.0%

Valuation

P/E0.0
P/B0.0
EV/EBITDA-31.9

Leverage

Debt/Equity0.06
Current Ratio0.08
Interest Cov.-5.6x

Quality Scores

Piotroski F5/9
Altman Z-0.05
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms